BioSpace News Archive

Policy

Ipsen Receives Positive CHMP Opinion for Cabometyx® (cabozantinib) for the First-Line Treatment of Adults with Intermediate- or Poor- Risk Advanced Renal Cell Carcinoma

Cabozantinib is the first and only monotherapy to demonstrate superior clinical efficacy over sunitinib in treatment-naïve patients with intermediate- or poor-risk aRCC.

March 23, 2018
·
13 min read
FDA

Canon Medical Systems’ Premium Ultrasound Provides New and Unique Features for a Wide Range of Liver Analysis

Industry’s Most Comprehensive Liver Analysis Suite with Attenuation Imaging and Shear Wave Dispersion

March 23, 2018
·
3 min read
Job Trends

Caris Life Sciences Announces Published Results Showing that its ADAPT Biotargeting System Effectively Stratified Breast Cancer Patients Based on Their Benefit from Trastuzumab Treatment (Herceptin)

Data featured in Nature Communications showed ADAPT Biotargeting System significantly out-performed industry standard HER2 testing

March 23, 2018
·
4 min read
Pharm Country

Anticancer Agent LENVIMA® Approved for Additional Indication of Unresectable Hepatocellular Carcinoma in Japan, First Approval Worldwide for LENVIMA for HCC

First New Front-Line Treatment Option for HCC Approved in Japan in Nearly 10 Years

March 23, 2018
·
40 min read
FDA

Smiths Medical Announces US Launch of the DeltaVen® Closed System Catheter and FDA Clearance

DeltaVen® is the next advancement in Peripheral IV Catheters.

March 23, 2018
·
1 min read
Business

Philips provides University of Ottawa Heart Institute with innovative health technology solutions for their expanded cardiovascular care facility

Philips delivers patient monitoring, cardiac ultrasound and image guided therapy solutions to Canada’s largest heart health centre.; Solutions-based approach to support the hospital in working to better understand, treat and prevent heart disease.

March 23, 2018
·
4 min read
Business

CBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 Antibody

Crown Bioscience and a global drug discovery and development services company announced a strategic licensing agreement with CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company.

March 23, 2018
·
3 min read